Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment

BACKGROUND: Despite promising advances in stem cell-based therapy, the treatment of ischemic cardiovascular diseases remains a big challenge due to both the insufficient in vivo viability of transplanted cells and poor angiogenic potential of stem cells. The goal of this study was to develop therape...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Tissue Eng Regen Med
Hoofdauteurs: Jang, Woong Bi, Ji, Seung Taek, Park, Ji Hye, Kim, Yeon-Ju, Kang, Songhwa, Kim, Da Yeon, Lee, Na-Kyung, Kim, Jin Su, Lim, Hye Ji, Choi, Jaewoo, Le, Thi Hong Van, Ly, Thanh Truong Giang, Rethineswaran, Vinoth Kumar, Kim, Dong Hwan, Ha, Jong Seong, Yun, Jisoo, Baek, Sang Hong, Kwon, Sang-Mo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Singapore 2020
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7260304/
https://ncbi.nlm.nih.gov/pubmed/32227286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13770-020-00244-w
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items